Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Apr 9, 2026
Date Accepted: Aug 5, 2026

The final, peer-reviewed published version of this preprint can be found here:

The Impact of Chatbot Type and Normative Messaging on Chatbot Usage Intention Based on the Health Technology Acceptance Model: Randomized Controlled Trial

Liao Y, Madeo A, Allen CG, Frey M, Maxwell W, Schlechter C, Sharaf R, Kawamoto K, Del Fiol G, Kaphingst KA

The Impact of Chatbot Type and Normative Messaging on Chatbot Usage Intention Based on the Health Technology Acceptance Model: Randomized Controlled Trial

J Med Internet Res 2026;28:e97773

DOI: 10.2196/97773

PMID: 42743590

The Impact of Chatbot Type and Normative Messaging on Chatbot Usage Intention: Randomized Controlled Trial Based on the Health Technology Acceptance Model

  • Yi Liao; 
  • Anne Madeo; 
  • Caitlin G Allen; 
  • Melissa Frey; 
  • Whitney Maxwell; 
  • Chelsey Schlechter; 
  • Ravi Sharaf; 
  • Kensaku Kawamoto; 
  • Guilherme Del Fiol; 
  • Kimberly A Kaphingst

ABSTRACT

Background:

Digital health tools such as health chatbots may improve access to scalable health support, but adoption remains inconsistent. Existing models do not fully integrate technology acceptance factors with health motivation factors relevant to digital health use.

Objective:

This study proposed and tested the health technology acceptance model (HTAM) and examined whether normative message framing and chatbot type were associated with health motivation, technology acceptance, and intention to use a health chatbot.

Methods:

In October 2025, we conducted a 4×2 between-subjects online experiment with 1000 US adults recruited from a nationally representative YouGov panel. Participants were randomized to 1 of 8 conditions varying norm message type (self-, peer-, expert-, or family-oriented) and chatbot type (artificial intelligence [AI] powered or rule-based) in a cancer prevention and genetic risk information scenario. Outcomes included descriptive norms, injunctive norms, perceived susceptibility, perceived severity, perceived benefits, self-efficacy, perceived ease of use, trust, privacy concerns, and usage intention. Data were analyzed using multivariate analysis of variance with Bonferroni-adjusted post hoc tests and multiple linear regression.

Results:

Peer- and family-oriented messages produced higher usage intention than expert-oriented messages, and peer-oriented messages also increased descriptive norms, injunctive norms, self-efficacy, and trust. AI-powered chatbots were associated with higher usage intention (P=.015) and greater trust (P=.008) than rule-based chatbots. In regression analyses, the model explained 50.8% of the variance in usage intention. Usage intention was positively associated with descriptive norms (β=.087; P=.003), injunctive norms (β =.078; P=.009), perceived susceptibility (β=.051; P=.027), perceived benefits (β=.253; P<.001), and trust (β=.33; P<.001), and negatively associated with perceived severity (b=-.047; P=.049) and privacy concerns (β=-.11; P<.001). Perceived ease of use and self-efficacy were not significant predictors.

Conclusions:

HTAM was a useful framework for explaining intention to use a health chatbot by combining technology acceptance and health motivation constructs. Both social design features and chatbot design features shaped adoption-related beliefs, with peer- and family-oriented framing and AI-powered chatbots showing particular promise. Trust and privacy concerns remained central determinants of intended use.


 Citation

Please cite as:

Liao Y, Madeo A, Allen CG, Frey M, Maxwell W, Schlechter C, Sharaf R, Kawamoto K, Del Fiol G, Kaphingst KA

The Impact of Chatbot Type and Normative Messaging on Chatbot Usage Intention Based on the Health Technology Acceptance Model: Randomized Controlled Trial

J Med Internet Res 2026;28:e97773

DOI: 10.2196/97773

PMID: 42743590

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.